Viatris Inc.: Hypertension trials

The registry lists 70 Hypertension studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 27 have results posted.

Phase 1 3Phase 2 4Phase 3 30Phase 4 15No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Oral Sildenafil on Mortality in Adults With PAHTerminatedNCT02060487Phase 4Results posted
• A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)CompletedNCT01801982Results posted
• A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The NewbornCompletedNCT01720524Phase 3Results posted
• Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial HypertensionCompletedNCT01642407Phase 4Results posted
• Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial HypertensionCompletedNCT01365585Results posted
• Amlodipine 10mg Drug Use InvestigationCompletedNCT01252563Results posted
• Long Term Use Of Xalacom In Patients Glaucoma Or Ocular HypertensionCompletedNCT01191008Results posted
• Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese PatientsCompletedNCT01190007Phase 4Results posted
• Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT01107743Results posted
• Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)TerminatedNCT01069861Phase 2Results posted
• Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And XalacomCompletedNCT01012245Results posted
• Efficacy and Tolerability of Xalatan in PatientsCompletedNCT00950690Results posted
• To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 WeeksCompletedNCT00946114Results posted
• Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT00749775Results posted
• Real Life Experience With Caduet In Patients With Cardiovascular Risk FactorsTerminatedNCT00579254Results posted
• A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And AtorvastatinCompletedNCT00530946Phase 3Results posted
• Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®CompletedNCT00486252Results posted
• Open Label Study of Sildenafil in Patients With Pulmonary Arterial HypertensionCompletedNCT00454207Phase 3Results posted
• To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.TerminatedNCT00430716Phase 4Results posted
• A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is InsufficientCompletedNCT00415623Phase 3Results posted
• Caduet vs Usual Care in Subjects With Hypertension and Additional Risk FactorsCompletedNCT00407537Phase 4Results posted
• A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).CompletedNCT00383019Phase 3Results posted
• Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00323297Phase 4Results posted
• A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.CompletedNCT00159913Phase 3Results posted
• A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In ChildrenCompletedNCT00159874Phase 3Results posted
• The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAHCompletedNCT00159861Phase 3Results posted
• Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With HypertensionCompletedNCT00142584Phase 3Results posted
• Revatio Special Investigation for Long-term Use in Pediatric PatientsCompletedNCT03364244
• Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With SildenafilNo longer availableNCT01897740
• Patient Reported Outcomes in Pulmonary Arterial HypertensionWithdrawnNCT01792622
• Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted ConditionCompletedNCT01389609Phase 1
• A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular HypertensionCompletedNCT01379144Phase 2
• IV Sildenafil Persistent Pulmonary Hypertension Of The NewbornWithdrawnNCT01360671Phase 2
• Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 StudyNo longer availableNCT00878943
• A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In PatientsCompletedNCT00856622Phase 3
• Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the USCompletedNCT00847483Phase 4
• Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.CompletedNCT00801437
• Sildenafil IV Bolus StudyCompletedNCT00800592Phase 1
• A Study of Glaucoma or Ocular Hypertension in Patients Within the United StatesCompletedNCT00800267Phase 3
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within ScandinaviaCompletedNCT00751062Phase 3
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United KingdomCompletedNCT00751049Phase 3
• Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' ManagementCompletedNCT00709787
• A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle GlaucomaCompletedNCT00647101Phase 4
• Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive PatientsCompletedNCT00646841Phase 4
• A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00644605Phase 3
• Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in CanadaCompletedNCT00334750
• Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and DyslipidaemiaCompletedNCT00330785Phase 3
• Cardiovascular Risk Assessment in Patients Treated With CaduetCompletedNCT00297973Phase 4
• Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery DeviceWithdrawnNCT00283764Phase 3
• A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaCompletedNCT00277498Phase 3
• Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular PressureCompletedNCT00230763Phase 3
• Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular HypertensionCompletedNCT00219596Phase 3
• A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive PatientsCompletedNCT00200499Phase 3
• A Study of the Safety and Efficacy of Nebivolol in Hypertensive PatientsCompletedNCT00200473Phase 3
• A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive PatientsCompletedNCT00200460Phase 3
• A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With HypertensionCompletedNCT00200434Phase 3
• A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate HypertensionCompletedNCT00200421Phase 2
• Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And DyslipidemiaCompletedNCT00174330Phase 4
• Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.CompletedNCT00174304Phase 4
• Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial HypertensionCompletedNCT00159887Phase 3
• Amlodipine Diabetic Hypertension Efficacy Response TrialCompletedNCT00159692Phase 4
• A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaCompletedNCT00159653Phase 3
• A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or PlaceboCompletedNCT00158093Phase 1
• To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .CompletedNCT00150358Phase 4
• The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 YearsCompletedNCT00147615Phase 3
• A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.CompletedNCT00147589Phase 3
• Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate HypertensionCompletedNCT00145236Phase 3
• Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African AmericansCompletedNCT00145210Phase 3
• Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol LevelsCompletedNCT00143234Phase 3
• A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ GlaucomaCompletedNCT00140049Phase 4